Science

Israeli scientists from the Weizmann Institute of Science say the method offers tools for understanding the formation of mammalian organs.

The Health Ministry gave interim approval to sell the spray to people aged 12 and over; UK clinical trial shows promising results.

Snakebite are a neglected tropical disease, says the World Health Organization, turning to the research community for help.

Viz.ai has raised more than $150 million in total funding for its AI healthcare solution.

EyeYon Medical's flagship product EndoArt enables doctors to treat chronic corneal edema with a minimally invasive surgery.

Early research shows the vaccine triggers an antibody response in breastmilk, potentially contributing to the protection of breastfed babies.

Israeli scientists draw a link between COVID-19 lockdowns and harmful secondary damage to people with diabetes.

The Nucleai team will have access to Sheba Medical Center's extensive repository of pathology, clinical, and other multi-omics data.

Doctors at Beilinson Hospital say a majority of patients given cannabidiol (CBD) to calm inflammation were released in under a month.

Israeli telehealth firm Tyto Care has raised $155 million to date.

The Sheba Medical Center came in 10th out of 200 hospitals ranked by Newsweek; the hospital made the top 10 for the 3rd consecutive year.

Theranica announced a milestone of more than 100,000 migraine treatments with the Nerivio device provided in the US.

Inspira's Augmented Respiration Technology (ART) will be tested in the intensive care unit (ICU) of Sheba's Department of Cardiac Surgery.

Founded in 2018, Immunai is on a mission to map out the immune system to improve immunotherapies and discover new treatments.

Dr. Fauci, director of the National Institute of Allergy and Infectious Diseases, was named among 7 recipients of the prestigious prize.